Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 939-943, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gunst, J. J.
Right arrow Articles by Leroux-Roels, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunst, J. J.
Right arrow Articles by Leroux-Roels, G. G.
Related Collections
Right arrow Nutrition
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Proteomics and Protein Markers
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1998;44:939-943.)
© 1998 American Association for Clinical Chemistry, Inc.

Enzymes and Protein Markers

Serum creatine kinase activity is not a reliable marker for muscle damage in conditions associated with low extracellular glutathione concentration

Johan J. Gunst, Michel R. Langlois, Joris R. Delanghea, Marc L. De Buyzere, and Geert G. Leroux-Roels

a Author for correspondence. Fax 32 9 240 4985; e-mail joris.delanghe{at}rug.ac.be.

Creatine kinase (CK, EC 2.7.3.2) assays usually contain thiol-reducing compounds to restore the enzyme activity. In this study, we investigated the effect of endogenous extracellular glutathione on serum CK activity. We examined CK activity and glutathione concentrations in serum from 200 healthy subjects (107 males, 93 females) and 38 patients with multiple organ failure, muscle wasting, and low serum CK activity (<50 U/L) (24 males, 14 females). Muscle damage was further evaluated using serum myoglobin concentrations and aldolase activity. In the overall group, serum glutathione concentrations correlated with serum CK activity (r = 0.791) but not with myoglobin concentrations and aldolase activity. In patients with multiple organ failure, low serum CK activities were accompanied by extremely low serum glutathione concentrations (<0.5 µmol/L, P <0.001). Endogenous glutathione can be regarded as a CK-preserving agent during the lifetime of the enzyme in the circulation (22 h on average). Serum CK activity should be interpreted with caution in patients with liver disease and multiple organ failure. In these conditions, the loss of CK activity due to extracellular glutathione depletion cannot be restored by the presence of thiol-reducing compounds in the CK assays.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
Y. E.C. Taes, N. H. Lameire, M. L. De Buyzere, A. Shoja, G. De Backer, and J. R. Delanghe
Exercise-induced Myocardial Ischemia Is Accompanied by Increased Serum Creatine Concentrations
Clin. Chem., April 1, 2003; 49(4): 684 - 686.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. A. Simpson, R. Labugger, G. G. Hesketh, C. D'Arsigny, D. O'Donnell, N. Matsumoto, C. P. Collier, S. Iscoe, and J. E. Van Eyk
Differential Detection of Skeletal Troponin I Isoforms in Serum of a Patient with Rhabdomyolysis: Markers of Muscle Injury?
Clin. Chem., July 1, 2002; 48(7): 1112 - 1114.
[Full Text] [PDF]

Home page
 Ann Rheum DisHome page
P D W KIELY, F E BRUCKNER, J A NISBET, and A DAGHIR
Serum skeletal troponin I in inflammatory muscle disease: relation to creatine kinase, CKMB and cardiac troponin I
Ann Rheum Dis, September 1, 2000; 59(9): 750 - 750.
[Full Text]

Home page
 Nephrol Dial TransplantHome page
C. Lowbeer, A. Ottosson-Seeberger, S. A. Gustafsson, R. Norrman, J. Hulting, and A. Gutierrez
Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease
Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1948 - 1955.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.